nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.053	0.111	CbGeAlD
Lisuride—Dementia—Riluzole—amyotrophic lateral sclerosis	0.048	0.0967	CcSEcCtD
Lisuride—Pericarditis—Riluzole—amyotrophic lateral sclerosis	0.0455	0.0917	CcSEcCtD
Lisuride—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.0327	0.0659	CcSEcCtD
Lisuride—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.0324	0.0652	CcSEcCtD
Lisuride—HTR1B—cranial nerve—amyotrophic lateral sclerosis	0.0287	0.06	CbGeAlD
Lisuride—HTR1D—cranial nerve—amyotrophic lateral sclerosis	0.0278	0.0581	CbGeAlD
Lisuride—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.0257	0.0518	CcSEcCtD
Lisuride—Methysergide—SIGMAR1—amyotrophic lateral sclerosis	0.0236	1	CrCbGaD
Lisuride—DRD1—nerve—amyotrophic lateral sclerosis	0.0182	0.038	CbGeAlD
Lisuride—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.0142	0.0286	CcSEcCtD
Lisuride—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.0138	0.0289	CbGeAlD
Lisuride—HTR2A—pons—amyotrophic lateral sclerosis	0.0136	0.0285	CbGeAlD
Lisuride—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0268	CcSEcCtD
Lisuride—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.0131	0.0263	CcSEcCtD
Lisuride—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0239	CcSEcCtD
Lisuride—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.0116	0.0243	CbGeAlD
Lisuride—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0227	CcSEcCtD
Lisuride—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0225	CcSEcCtD
Lisuride—DRD2—nerve—amyotrophic lateral sclerosis	0.0107	0.0224	CbGeAlD
Lisuride—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.0107	0.0223	CbGeAlD
Lisuride—Sweating—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0213	CcSEcCtD
Lisuride—HTR2A—appendage—amyotrophic lateral sclerosis	0.00998	0.0209	CbGeAlD
Lisuride—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00984	0.0198	CcSEcCtD
Lisuride—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00974	0.0196	CcSEcCtD
Lisuride—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00917	0.0185	CcSEcCtD
Lisuride—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00907	0.019	CbGeAlD
Lisuride—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00897	0.0181	CcSEcCtD
Lisuride—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00893	0.018	CcSEcCtD
Lisuride—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00891	0.018	CcSEcCtD
Lisuride—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.00889	0.0186	CbGeAlD
Lisuride—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00866	0.0175	CcSEcCtD
Lisuride—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00861	0.0173	CcSEcCtD
Lisuride—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00803	0.0168	CbGeAlD
Lisuride—DRD1—brainstem—amyotrophic lateral sclerosis	0.00779	0.0163	CbGeAlD
Lisuride—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00773	0.0156	CcSEcCtD
Lisuride—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00772	0.0156	CcSEcCtD
Lisuride—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.0076	0.0153	CcSEcCtD
Lisuride—Cough—Riluzole—amyotrophic lateral sclerosis	0.00751	0.0151	CcSEcCtD
Lisuride—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.0073	0.0147	CcSEcCtD
Lisuride—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00717	0.0144	CcSEcCtD
Lisuride—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00708	0.0143	CcSEcCtD
Lisuride—HTR2A—nerve—amyotrophic lateral sclerosis	0.00707	0.0148	CbGeAlD
Lisuride—Infection—Riluzole—amyotrophic lateral sclerosis	0.00698	0.0141	CcSEcCtD
Lisuride—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00689	0.0139	CcSEcCtD
Lisuride—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00685	0.0138	CcSEcCtD
Lisuride—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00679	0.0137	CcSEcCtD
Lisuride—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00669	0.0135	CcSEcCtD
Lisuride—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00635	0.0128	CcSEcCtD
Lisuride—HTR1B—brainstem—amyotrophic lateral sclerosis	0.00631	0.0132	CbGeAlD
Lisuride—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00626	0.0126	CcSEcCtD
Lisuride—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00624	0.0126	CcSEcCtD
Lisuride—DRD4—brain—amyotrophic lateral sclerosis	0.0062	0.013	CbGeAlD
Lisuride—HTR1D—brainstem—amyotrophic lateral sclerosis	0.00611	0.0128	CbGeAlD
Lisuride—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00611	0.0123	CcSEcCtD
Lisuride—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00606	0.0122	CcSEcCtD
Lisuride—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00606	0.0122	CcSEcCtD
Lisuride—HTR2C—brainstem—amyotrophic lateral sclerosis	0.00605	0.0127	CbGeAlD
Lisuride—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00601	0.0121	CcSEcCtD
Lisuride—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00579	0.0117	CcSEcCtD
Lisuride—DRD3—nervous system—amyotrophic lateral sclerosis	0.0057	0.0119	CbGeAlD
Lisuride—DRD3—central nervous system—amyotrophic lateral sclerosis	0.00549	0.0115	CbGeAlD
Lisuride—DRD5—nervous system—amyotrophic lateral sclerosis	0.00534	0.0112	CbGeAlD
Lisuride—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.0053	0.0111	CbGeAlD
Lisuride—DRD5—central nervous system—amyotrophic lateral sclerosis	0.00514	0.0108	CbGeAlD
Lisuride—HTR1A—brainstem—amyotrophic lateral sclerosis	0.0051	0.0107	CbGeAlD
Lisuride—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00504	0.0102	CcSEcCtD
Lisuride—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00483	0.0101	CbGeAlD
Lisuride—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00464	0.00936	CcSEcCtD
Lisuride—DRD2—brainstem—amyotrophic lateral sclerosis	0.0046	0.00963	CbGeAlD
Lisuride—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00447	0.009	CcSEcCtD
Lisuride—Headache—Riluzole—amyotrophic lateral sclerosis	0.0044	0.00887	CcSEcCtD
Lisuride—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.00438	0.00916	CbGeAlD
Lisuride—DRD3—brain—amyotrophic lateral sclerosis	0.00436	0.00911	CbGeAlD
Lisuride—ADRA1D—nervous system—amyotrophic lateral sclerosis	0.00428	0.00896	CbGeAlD
Lisuride—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00422	0.00883	CbGeAlD
Lisuride—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.00422	0.00882	CbGeAlD
Lisuride—ADRA1D—central nervous system—amyotrophic lateral sclerosis	0.00413	0.00862	CbGeAlD
Lisuride—DRD5—brain—amyotrophic lateral sclerosis	0.00408	0.00854	CbGeAlD
Lisuride—DRD1—nervous system—amyotrophic lateral sclerosis	0.00408	0.00854	CbGeAlD
Lisuride—DRD1—central nervous system—amyotrophic lateral sclerosis	0.00393	0.00822	CbGeAlD
Lisuride—HTR1B—spinal cord—amyotrophic lateral sclerosis	0.00393	0.00821	CbGeAlD
Lisuride—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00376	0.00787	CbGeAlD
Lisuride—ADRA1B—brain—amyotrophic lateral sclerosis	0.00335	0.007	CbGeAlD
Lisuride—HTR2A—embryo—amyotrophic lateral sclerosis	0.00331	0.00693	CbGeAlD
Lisuride—HTR1B—nervous system—amyotrophic lateral sclerosis	0.00331	0.00692	CbGeAlD
Lisuride—ADRA1D—brain—amyotrophic lateral sclerosis	0.00328	0.00685	CbGeAlD
Lisuride—HTR1D—nervous system—amyotrophic lateral sclerosis	0.0032	0.0067	CbGeAlD
Lisuride—HTR1B—central nervous system—amyotrophic lateral sclerosis	0.00319	0.00666	CbGeAlD
Lisuride—HTR2C—nervous system—amyotrophic lateral sclerosis	0.00317	0.00663	CbGeAlD
Lisuride—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.00317	0.00662	CbGeAlD
Lisuride—ADRA2C—medulla oblongata—amyotrophic lateral sclerosis	0.00312	0.00653	CbGeAlD
Lisuride—DRD1—brain—amyotrophic lateral sclerosis	0.00312	0.00652	CbGeAlD
Lisuride—ADRB1—nervous system—amyotrophic lateral sclerosis	0.00311	0.00651	CbGeAlD
Lisuride—HTR1D—central nervous system—amyotrophic lateral sclerosis	0.00308	0.00645	CbGeAlD
Lisuride—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.00305	0.00638	CbGeAlD
Lisuride—HTR2A—brainstem—amyotrophic lateral sclerosis	0.00304	0.00635	CbGeAlD
Lisuride—ADRB1—central nervous system—amyotrophic lateral sclerosis	0.003	0.00626	CbGeAlD
Lisuride—HTR2B—nervous system—amyotrophic lateral sclerosis	0.00298	0.00623	CbGeAlD
Lisuride—HTR2B—central nervous system—amyotrophic lateral sclerosis	0.00287	0.006	CbGeAlD
Lisuride—ADRA2C—spinal cord—amyotrophic lateral sclerosis	0.00278	0.00582	CbGeAlD
Lisuride—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00277	0.00578	CbGeAlD
Lisuride—HTR1A—nervous system—amyotrophic lateral sclerosis	0.00267	0.00558	CbGeAlD
Lisuride—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.00257	0.00537	CbGeAlD
Lisuride—HTR1B—brain—amyotrophic lateral sclerosis	0.00253	0.00529	CbGeAlD
Lisuride—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.00251	0.00525	CbGeAlD
Lisuride—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00249	0.00521	CbGeAlD
Lisuride—HTR1D—brain—amyotrophic lateral sclerosis	0.00245	0.00512	CbGeAlD
Lisuride—HTR2C—brain—amyotrophic lateral sclerosis	0.00242	0.00507	CbGeAlD
Lisuride—DRD2—nervous system—amyotrophic lateral sclerosis	0.00241	0.00504	CbGeAlD
Lisuride—ADRB1—brain—amyotrophic lateral sclerosis	0.00238	0.00497	CbGeAlD
Lisuride—ADRA2C—nervous system—amyotrophic lateral sclerosis	0.00235	0.0049	CbGeAlD
Lisuride—DRD2—central nervous system—amyotrophic lateral sclerosis	0.00232	0.00486	CbGeAlD
Lisuride—HTR2B—brain—amyotrophic lateral sclerosis	0.00228	0.00476	CbGeAlD
Lisuride—DRD2—cerebellum—amyotrophic lateral sclerosis	0.00227	0.00475	CbGeAlD
Lisuride—ADRA2C—central nervous system—amyotrophic lateral sclerosis	0.00226	0.00472	CbGeAlD
Lisuride—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.00222	0.00464	CbGeAlD
Lisuride—ADRA2C—cerebellum—amyotrophic lateral sclerosis	0.00221	0.00461	CbGeAlD
Lisuride—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.00212	0.00443	CbGeAlD
Lisuride—HTR1A—brain—amyotrophic lateral sclerosis	0.00204	0.00427	CbGeAlD
Lisuride—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.00189	0.00395	CbGeAlD
Lisuride—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.00187	0.00391	CbGeAlD
Lisuride—DRD2—brain—amyotrophic lateral sclerosis	0.00184	0.00385	CbGeAlD
Lisuride—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.0018	0.00377	CbGeAlD
Lisuride—ADRA2C—brain—amyotrophic lateral sclerosis	0.00179	0.00375	CbGeAlD
Lisuride—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.00176	0.00368	CbGeAlD
Lisuride—HTR2A—nervous system—amyotrophic lateral sclerosis	0.00159	0.00333	CbGeAlD
Lisuride—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.00153	0.0032	CbGeAlD
Lisuride—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.0015	0.00313	CbGeAlD
Lisuride—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00147	0.00308	CbGeAlD
Lisuride—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.00145	0.00303	CbGeAlD
Lisuride—ADRA2A—brain—amyotrophic lateral sclerosis	0.00143	0.00299	CbGeAlD
Lisuride—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00142	0.00296	CbGeAlD
Lisuride—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.0014	0.00292	CbGeAlD
Lisuride—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.00136	0.00285	CbGeAlD
Lisuride—HTR2A—brain—amyotrophic lateral sclerosis	0.00122	0.00254	CbGeAlD
Lisuride—CYP2D6—brain—amyotrophic lateral sclerosis	0.00111	0.00232	CbGeAlD
Lisuride—HTR1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.23e-06	0.000653	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.23e-06	0.00065	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.22e-06	0.000649	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.21e-06	0.000642	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.21e-06	0.00064	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.2e-06	0.000635	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.19e-06	0.000632	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.19e-06	0.000632	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.19e-06	0.000631	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.19e-06	0.000629	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.18e-06	0.000624	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.17e-06	0.000622	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.17e-06	0.000621	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.17e-06	0.00062	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.17e-06	0.000619	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.16e-06	0.000615	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.16e-06	0.000615	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.16e-06	0.000615	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.16e-06	0.000614	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.15e-06	0.000608	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.14e-06	0.000605	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.14e-06	0.000603	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.13e-06	0.000602	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.13e-06	0.000598	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.12e-06	0.000596	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.11e-06	0.000591	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.1e-06	0.000585	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.1e-06	0.000582	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.09e-06	0.000577	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.09e-06	0.000577	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.09e-06	0.000577	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.08e-06	0.000574	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.08e-06	0.000573	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.06e-06	0.000564	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.06e-06	0.000561	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.05e-06	0.000558	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.05e-06	0.000558	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.05e-06	0.000557	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.05e-06	0.000556	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.05e-06	0.000555	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.04e-06	0.00055	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.04e-06	0.00055	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.04e-06	0.00055	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.04e-06	0.000549	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.03e-06	0.000549	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.03e-06	0.000544	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.02e-06	0.000538	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.01e-06	0.000536	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.01e-06	0.000534	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.99e-07	0.00053	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.92e-07	0.000526	CbGpPWpGaD
Lisuride—ADRA2B—Hemostasis—VEGFA—amyotrophic lateral sclerosis	9.86e-07	0.000523	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.83e-07	0.000521	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	9.79e-07	0.000519	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.75e-07	0.000517	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	9.67e-07	0.000513	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	9.63e-07	0.000511	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	9.55e-07	0.000506	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.54e-07	0.000506	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.53e-07	0.000506	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.49e-07	0.000503	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.44e-07	0.000501	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.44e-07	0.0005	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	9.41e-07	0.000499	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	9.4e-07	0.000498	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.39e-07	0.000498	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.36e-07	0.000496	CbGpPWpGaD
Lisuride—ADRA2C—Hemostasis—VEGFA—amyotrophic lateral sclerosis	9.21e-07	0.000489	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.18e-07	0.000487	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.15e-07	0.000486	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.03e-07	0.000479	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.03e-07	0.000479	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	9.02e-07	0.000478	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.99e-07	0.000477	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.99e-07	0.000477	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.96e-07	0.000475	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.88e-07	0.000471	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.87e-07	0.000471	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.87e-07	0.000471	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.74e-07	0.000464	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.74e-07	0.000463	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.65e-07	0.000459	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.61e-07	0.000457	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.6e-07	0.000456	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	8.55e-07	0.000453	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.45e-07	0.000448	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.43e-07	0.000447	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.41e-07	0.000446	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.34e-07	0.000442	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.34e-07	0.000442	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.33e-07	0.000442	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.3e-07	0.00044	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.19e-07	0.000435	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.08e-07	0.000429	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.02e-07	0.000425	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.01e-07	0.000425	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.95e-07	0.000422	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.93e-07	0.000421	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.92e-07	0.00042	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.85e-07	0.000416	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.8e-07	0.000414	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	7.78e-07	0.000413	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.73e-07	0.00041	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.73e-07	0.00041	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.69e-07	0.000408	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.6e-07	0.000403	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.53e-07	0.000399	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	7.48e-07	0.000397	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.48e-07	0.000397	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.47e-07	0.000396	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.45e-07	0.000395	CbGpPWpGaD
Lisuride—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	7.45e-07	0.000395	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.44e-07	0.000394	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.38e-07	0.000391	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.37e-07	0.000391	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.37e-07	0.000391	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.36e-07	0.000391	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.27e-07	0.000386	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.23e-07	0.000384	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	7.18e-07	0.000381	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.1e-07	0.000377	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.03e-07	0.000373	CbGpPWpGaD
Lisuride—ADRA2C—Hemostasis—TP53—amyotrophic lateral sclerosis	6.96e-07	0.000369	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.96e-07	0.000369	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.92e-07	0.000367	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—APOE—amyotrophic lateral sclerosis	6.92e-07	0.000367	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.86e-07	0.000364	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.86e-07	0.000364	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.83e-07	0.000362	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.79e-07	0.00036	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.72e-07	0.000356	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.68e-07	0.000354	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.66e-07	0.000353	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.66e-07	0.000353	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.63e-07	0.000351	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.49e-07	0.000344	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.42e-07	0.000341	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.39e-07	0.000339	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.38e-07	0.000339	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.38e-07	0.000339	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.29e-07	0.000334	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.28e-07	0.000333	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.25e-07	0.000332	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.22e-07	0.00033	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.2e-07	0.000329	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.12e-07	0.000325	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.09e-07	0.000323	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.08e-07	0.000322	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.98e-07	0.000317	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.95e-07	0.000316	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	5.89e-07	0.000313	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.79e-07	0.000307	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.75e-07	0.000305	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.71e-07	0.000303	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.7e-07	0.000302	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.67e-07	0.000301	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.67e-07	0.000301	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	5.66e-07	0.0003	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.65e-07	0.0003	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.64e-07	0.000299	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	5.62e-07	0.000298	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.55e-07	0.000294	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.25e-07	0.000279	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.17e-07	0.000274	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.17e-07	0.000274	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.12e-07	0.000272	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.1e-07	0.000271	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.05e-07	0.000268	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.99e-07	0.000265	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.94e-07	0.000262	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.92e-07	0.000261	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.91e-07	0.000261	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.85e-07	0.000257	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.82e-07	0.000256	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.78e-07	0.000254	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.74e-07	0.000252	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.72e-07	0.00025	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.71e-07	0.00025	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.7e-07	0.000249	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.69e-07	0.000249	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.64e-07	0.000246	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.45e-07	0.000236	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.43e-07	0.000235	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.42e-07	0.000235	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.37e-07	0.000232	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.37e-07	0.000232	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.34e-07	0.00023	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.33e-07	0.00023	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.27e-07	0.000226	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.27e-07	0.000226	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.24e-07	0.000225	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.18e-07	0.000222	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.17e-07	0.000221	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.13e-07	0.000219	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.13e-07	0.000219	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.98e-07	0.000211	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.98e-07	0.000211	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.94e-07	0.000209	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.88e-07	0.000206	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.85e-07	0.000204	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.8e-07	0.000202	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.78e-07	0.000201	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.76e-07	0.000199	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.75e-07	0.000199	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.72e-07	0.000198	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.7e-07	0.000196	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.7e-07	0.000196	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.68e-07	0.000195	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	3.66e-07	0.000194	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.62e-07	0.000192	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.6e-07	0.000191	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.58e-07	0.00019	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.48e-07	0.000185	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.42e-07	0.000182	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.38e-07	0.000179	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.34e-07	0.000177	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.34e-07	0.000177	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.29e-07	0.000174	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.27e-07	0.000173	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.23e-07	0.000171	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.21e-07	0.00017	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.2e-07	0.00017	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.17e-07	0.000168	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.16e-07	0.000167	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.15e-07	0.000167	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.12e-07	0.000166	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.11e-07	0.000165	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.07e-07	0.000163	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.01e-07	0.00016	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.99e-07	0.000159	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.91e-07	0.000154	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.84e-07	0.00015	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.83e-07	0.00015	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.83e-07	0.00015	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.8e-07	0.000148	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.8e-07	0.000148	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.79e-07	0.000148	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.55e-07	0.000135	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.54e-07	0.000135	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.53e-07	0.000134	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.51e-07	0.000133	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.44e-07	0.000129	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.43e-07	0.000129	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.4e-07	0.000127	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.36e-07	0.000125	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.32e-07	0.000123	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.14e-07	0.000114	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.11e-07	0.000112	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.92e-07	0.000102	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.64e-07	8.7e-05	CbGpPWpGaD
